![](/img/cover-not-exists.png)
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-Resistant Tumors
Chamberlain, Chester E., German, Michael S, Yang, Katherine, Wang, Jason, VanBrocklin, Henry, Regan, Melanie, Shokat, Kevan M., Ducker, Gregory S, Kim, Grace E., Hann, Byron, Donner, David B, Warren,Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-1204
Date:
September, 2018
File:
PDF, 2.44 MB
english, 2018